Skip Nav Destination
Article navigation
Meeting Abstracts|
September 1988
A PRINCIPAL METABOLITE OF 2-CHL0ROPR0CAINE DOES NOT ACT AS A U-OPIATE RECEPTOR ANTAGONIST IN THE DOG
Department of Anesthesiologyy, Michael Reese Hospital and Medical Center, Chicago, IL 60616
Anesthesiology September 1988, Vol. 69, A359.
Citation
N. N. Naughton, D. A. Pelligrino, R. F. Albrecht; A PRINCIPAL METABOLITE OF 2-CHL0ROPR0CAINE DOES NOT ACT AS A U-OPIATE RECEPTOR ANTAGONIST IN THE DOG. Anesthesiology 1988; 69:A359 doi: https://doi.org/10.1097/00000542-198809010-00358
Download citation file:
Citing articles via
Most Viewed
Related Articles
Intraoperative Ketamine Reduces Perioperative Opiate Consumption in Opiate-dependent Patients with Chronic Back Pain Undergoing Back Surgery
Anesthesiology (September 2010)
Antinociceptive Response to Nitrous Oxide Is Mediated by Supraspinal Opiate and Spinal α 2 Adrenergic Receptors in the Rat
Anesthesiology (October 1996)
Buprenorphine Metabolites, Buprenorphine-3-glucuronide and Norbuprenorphine-3-glucuronide, Are Biologically Active
Anesthesiology (December 2011)
Toxicologic and Inhibitory Receptor Actions of the Etomidate Analog ABP-700 and Its Metabolite CPM-Acid
Anesthesiology (August 2019)
Opiate Pharmacology of Intrathecal Granulomas
Anesthesiology (September 2006)